reports
Moody's Ratings downgrades Lakeshore's CFR to B3 from B2; outlook is s...
Moody's Ratings (Moody's) downgraded Lakeshore Learning Materials, LLC's (Lakeshore) ratings including the Corporate Family Rating to B3 from B2, Probability of Default Rating to B3-PD from B2-PD and senior secured first lien term loan rating to B3 from B2. The outlook is stable. The downgrade ref...
Moody's Ratings assigns Aa2 to NYC HDC's Multi-Fam Hsg Rev Bonds, 2025...
Moody's Ratings (Moody's) has assigned a Aa2 rating to the proposed New York City Housing Development Corporation, NY's (the Corporation's) $63.9 million Multi-Family Housing Revenue Bonds, 2025 Series B-1 (Sustainable Development Bonds) and $93.4 million Multi-Family Housing Revenue Bonds, 2025 B-2...
Moody's Ratings assigns ratings to three classes of CLO refinancing no...
Moody's Ratings (Moody's) has assigned ratings to three classes of CLO refinancing notes issued and one class of loans incurred by AGL CLO 6 Ltd. (the Issuer): U.S.$5,500,000 Class X Senior Secured Floating Rate Notes due 2038, Assigned Aaa (sf) U.S.$184,600,000 Class A-1RR Senior Secured Floatin...
Interfor to Announce First Quarter Results on May 8, 2025
Interfor to Announce First Quarter Results on May 8, 2025 Analyst Conference Call – 8:00 a.m. Pacific, Friday, May 9, 2025 BURNABY, British Columbia, April 08, 2025 (GLOBE NEWSWIRE) -- INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) will release its first quarter financial results on May 8, 2025. The analyst conference call is scheduled for 8:00 am Pacific on Friday, May 9, 2025 and will feature a brief summary of financial results by Interfor management followed by a question and answer period with analysts. WHEN:Friday, May 9, 2025 at 8:00 am PTCALL DETAILS:1-888-51...
- Benjamin Schroeder
- Padhraic Garvey
- CFA
Rates Spark: Is sell America Inc. now a thing?
US Treasuries are not behaving as a safe haven. They have cheapened versus the risk free rate, in a significant manner. The 3yr auction was a mess. There is now heightened nervousness ahead of the 10yr auction. This seemingly 'sell America' trade, is one that's now dominating the rising recession risk theme that typically would have pushed yields down
First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Tri...
First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients LA JOLLA, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced enrollment of the first patient in the NIH-funded Expanded Access Program (EAP) trial to evaluate MN-166 (ibudilast) in patients with Amyotrophic Lateral Sclerosis (ALS). This significant milestone marks the beginni...
Moody's Ratings upgrades ratings on two classes of notes issued by Cre...
Moody's Ratings (Moody's) has upgraded the ratings on the following notes issued by Crestline Denali CLO XVII, Ltd.: U.S.$20,000,000 Class C-R Senior Secured Deferrable Floating Rate Notes due 2031 (the "Class C-R Notes"), Upgraded to Aa1 (sf); previously on June 20, 2024 Assigned A1 (sf) U.S.$26...
Titan Acquisition Corp Announces Pricing of $240,000,000 Initial Publi...
Titan Acquisition Corp Announces Pricing of $240,000,000 Initial Public Offering BROOKLYN, New York, April 08, 2025 (GLOBE NEWSWIRE) -- Titan Acquisition Corp (Nasdaq: TACHU) (the “Company”) announced today the pricing of its initial public offering of 24,000,000 units at $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “TACHU” beginning April 9, 2025. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Once the securities comprising the units begin separate trading, the Class...
Alliancebernstein Holding Lp: 3 directors
Three Directors at Alliancebernstein Holding Lp sold 109,813 shares at 38.500USD. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
Moody's Ratings assigns Aa2 to Missouri State Environmental Improvemen...
Moody's Ratings (Moody's) has assigned an Aa2 rating to Missouri State Environmental Improvement and Energy Resources Authority (EIERA), MO's proposed approximately $32.5 million Solid Waste Disposal Revenue Bonds (City of Springfield, Missouri Noble Hill Sanitary Landfill Project), Series 2025. At ...
GMS Inc: 1 director
A director at GMS Inc bought 3,650 shares at 70.000USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
Moody's Ratings assigns A1 to Pittsburg USD, CA's 2025 GO bonds; outlo...
Moody's Ratings (Moody's) has assigned A1 ratings to Pittsburg Unified School District, CA's General Obligation Bonds Election of 2024, Series A (2025) and 2025 General Obligation Refunding Bonds. The expected par amounts are about $45 million and $53.8 million, respectively. We maintain the distric...
- Miika Ihamaki
Tokmanni (Buy, TP: EUR13.50) - Aisle of opportunity
We have upgraded Tokmanni to BUY (HOLD) and raised our target price to EUR13.5 (13.0). We believe the recent market reaction overly penalised Tokmanni, with a PEG of c0.6x offering a good entry point in one of the largest variety discounters in the Nordics. Although overall economic uncertainty has risen, we believe Tokmanni’s low exposure to cyclical demand supports sustained growth and continue to see higher margins through operational scaling. For Q1e, we are close to consensus and expect 202...
Humacyte Inc: 3 directors
Three Directors at Humacyte Inc bought 72,000 shares at between 1.260USD and 1.320USD. The significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Thermo Fisher Scientific Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 4 April 2025 in which we reassessed the appropriateness of the ratings in the...
EQS-News: Redcare platziert erfolgreich neue Wandelschuldverschreibung...
EQS-News: Redcare Pharmacy N.V. / Schlagwort(e): Anleiheemission/Finanzierung Redcare platziert erfolgreich neue Wandelschuldverschreibungen und kauft einen Teil der ausstehenden Wandelschuldverschreibungen zurück. 08.04.2025 / 23:45 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. DIESE MITTEILUNG, EINSCHLIESSLICH DER HIERIN ENTHALTENEN INFORMATIONEN, UNTERLIEGT EINSCHRÄNKUNGEN UND DARF WEDER DIREKT NOCH INDIREKT IN DEN VEREINIGTEN STAATEN VON AMERIKA, AUSTRALIEN, JAPAN, SÜDAFRIKA ODER EINER ANDEREN RECHTSORDNUNG, IN DER ODER AN PERSO...
EQS-News: Redcare successfully executes placement of new convertible b...
EQS-News: Redcare Pharmacy N.V. / Key word(s): Issue of Debt/Financing Redcare successfully executes placement of new convertible bonds and buys back part of the outstanding convertible bonds. 08.04.2025 / 23:45 CET/CEST The issuer is solely responsible for the content of this announcement. THIS ANNOUNCEMENT, INCLUDING THE INFORMATION INCLUDED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURI...
Moody's Ratings assigns credit enhanced Aa2 to Custodial Receipts (Bar...
Moody's Ratings (Moody's) has assigned credit enhanced Aa2 to the Custodial Receipts (Barclays), Custodial Receipts, Series 2025-XF3348 (the Receipts) evidencing ownership of Louisiana Public Facilities Authority, Senior Lien Revenue Bonds (I-10 Calcasieu River Bridge Public-Private Partnership Proj...
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of MoneyGram International, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 4 April 2025 in which we reassessed the appropriateness of the ratings in the...
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Ev...
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs WARREN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: ), a healthcare company with dedicated efforts in immunotherapy and artificial intelligence, today announced that Mittul Mehta, Chief Information Officer and Head of Tevogen.AI, presented at AI x Bio Philly, a premier event highlighting the convergence of artificial intelligence and life sciences in the Philadelphia region. Hosted by BioBuzz, BitsInBio, Atria, and Zetta, AI...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.